PositiveID Corporation (OTC: PSID) is a life sciences and technology company focused primarily on the healthcare and homeland security markets. Within our detection and diagnostics business, we specialize in the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations and analyze biological samples at the point of need. Our Thermomedics subsidiary markets the Caregiver(R) non-contact thermometer to the professional healthcare market. Our E-N-G subsidiary manufactures specialty technology vehicles, focused on mobile labs. PositiveID has a substantial portfolio of intellectual property related primarily to sample preparation and rapid medical testing applications, and the Caregiver non-contact thermometer. PositiveID's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security (DHS) Science & Technology directorate, and $30 million of contract funding. M-BAND continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins. PositiveID's FireflyDX, being developed by its ExcitePCR subsidiary, is a point-of-need, handheld system designed to deliver molecular diagnostic results using real-time PCR (polymerase chain reaction) chemistry. Firefly is being developed to meet the growing need in healthcare and molecular diagnostics markets by enabling hospitals, physicians and other providers to save lives and fight disease. PSID has offices in Delray Beach, Florida, Concord, CA, and Pleasanton, California. www.psidcorp.com
